May 31, 2018
|
June 12, 2018
|
June 19, 2018
|
November 1, 2017
|
March 2, 2018 (Final data collection date for primary outcome measure)
|
pain explicit declaration of intent [ Time Frame: 30 minutes ] presence or absence of dental hyperalgesia and mechanical allodynia was recorded as well as the intensity of pain according to visual analog scale (VAS) with patients request of treatment to further evaluate any relevance between the variables. VAS scale is between 1 to 10 and 1 means no pain and 10 means worst pain ever. The scale was drawn as a 10 cm line on a paper, with a number at the beginning of each cm from 1 to 10 and patients were asked to show the respected place regarding their intensity of pain they were experiencing on the line.
|
pain explicit declaration of intent [ Time Frame: 30 minutes ] presence or absence of dental hyperalgesia and mechanical allodynia was recorded as well as the intensity of pain according to visual analog scale with patients request of treatment to further evaluate any relevance between the variables
|
|
- aesthetics [ Time Frame: 30 minutes ]
patient who chose extraction were asked their choice of treatment if the relevant tooth were to be an anterior tooth and recorded as yes or no
- previous RCT [ Time Frame: 30 minutes ]
patients were asked if they had any root canal treatment previously and recorded as yes or no
- excessive pain [ Time Frame: 30 minutes ]
patient who chose extraction were asked their choice of treatment if the painh were not to be excessive and recorded as yes or no
|
Same as current
|
Not Provided
|
Not Provided
|
|
The Effect of Central Sensitization on Assessment Capacity of Patients
|
The Effect of Dental Hyperalgesia and Mechanical Allodynia on Assessment Capacity of Patients in a Local Turkish Population
|
the aim of this study is to evaluate the effect of dental hyperalgesia and mechanical allodynia on the assessment capacity of individuals in a local Turkish population. The hypothesis of this study is that excessive amounts of pain and a major functional shift in the somatosensory system due to central sensitization might cause unwitting intent.
|
It included patients between the ages of 18 and 70 who had a symptomatic tooth in need of non-surgical root canal treatment. All enrolled subjects volunteered and signed a written informed consent. Patients diagnosed with systemic diseases and those who had used an analgesic within 12 hours prior to the appointment were excluded from the study. A total of 30 patients were included in the study. A data sheet including patients' demographic data, diagnostic data, and data of explicit declaration of intent was completed. All pain scores were recorded according to the Visual Analog Scale (VAS). After the demographic data, diagnostic data. Patients were explicitly informed that the answers they were going to provide to the questions related to their explicit declaration of intent would not affect their diagnosis or the treatment they would undergo.
|
Observational [Patient Registry]
|
Observational Model: Cohort Time Perspective: Cross-Sectional
|
1 Day
|
Not Provided
|
Non-Probability Sample
|
non
|
- Symptomatic Irreversible Pulpitis
- Acute Apical Periodontitis of Pulpal Origin
|
Not Provided
|
Not Provided
|
Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000 Jun 9;288(5472):1765-9. Review.
|
|
Completed
|
30
|
Same as current
|
March 2, 2018
|
March 2, 2018 (Final data collection date for primary outcome measure)
|
Inclusion Criteria:
- patients between the ages of 18 and 70 who had a symptomatic tooth in need of non-surgical root canal treatment. All enrolled subjects volunteered and signed a written informed consent
Exclusion Criteria:
- Patients diagnosed with systemic diseases and those who had used an analgesic within 12 hours prior to the appointment were excluded from the study.
|
Sexes Eligible for Study: |
All |
|
18 Years to 70 Years (Adult, Older Adult)
|
Yes
|
Contact information is only displayed when the study is recruiting subjects
|
Turkey
|
|
|
NCT03553641
|
404
|
No
|
Studies a U.S. FDA-regulated Drug Product: |
No |
Studies a U.S. FDA-regulated Device Product: |
No |
|
Plan to Share IPD: |
No |
Plan Description: |
name of the study and name of the researchers |
|
Tan Firat Eyuboglu, Istanbul Medipol University Hospital
|
Istanbul Medipol University Hospital
|
Not Provided
|
Principal Investigator: |
Tan F EYUBOGLU, PROF |
Istanbul Medipol University Faculty of Dentistry |
Principal Investigator: |
Fulya I GONENC, PROF |
Istanbul Medipol University Faculty of Law |
|
Istanbul Medipol University Hospital
|
June 2018
|